SCHEDULE: Vanguard Group Exits Outset Medical Direct Stake

The Vanguard Group reports zero beneficial ownership in Outset Medical Inc. following an internal reporting realignment.

Summary

• The Vanguard Group filed an Amendment No. 1 to its Schedule 13G for Outset Medical Inc. Common Stock.
• The filing indicates that The Vanguard Group now holds 0 shares, representing 0% of the Common Stock of Outset Medical Inc.
• This change is attributed to an internal realignment within The Vanguard Group, Inc. on January 12, 2026.
• Following the realignment, certain subsidiaries or business divisions of The Vanguard Group, Inc. will report their beneficial ownership separately (on a disaggregated basis).
• The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by these disaggregated entities.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral for Outset Medical Inc. as it primarily reflects an internal reporting change by The Vanguard Group rather than a change in investment thesis or performance of the issuer.

Positives

• Clarity regarding The Vanguard Group's beneficial ownership structure following an internal realignment.

Negatives

• The Vanguard Group no longer directly reports beneficial ownership of Outset Medical Inc. common stock, which might initially be misinterpreted as a divestment.

Risks

• Potential for misinterpretation of The Vanguard Group's overall investment strategy in Outset Medical Inc. due to the shift to disaggregated reporting by its subsidiaries.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding Outset Medical Inc.'s operations or financial performance, as it pertains solely to The Vanguard Group's reporting of beneficial ownership.

Management Comments

• "On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release."
• "These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment."
• "Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions."

Industry Context

StockSavvy.ai notes that institutional investors like The Vanguard Group frequently undergo internal restructurings or reallocations of reporting responsibilities. This filing reflects a procedural change in how Vanguard reports its holdings rather than a strategic divestment from Outset Medical Inc. by the broader Vanguard ecosystem. Other large asset managers also employ similar disaggregated reporting for their various funds and divisions.

Comparison to Industry Standards

• This filing aligns with standard SEC reporting requirements for institutional investors, specifically Schedule 13G, which is used by passive investors.
• The internal realignment and subsequent disaggregated reporting by The Vanguard Group are consistent with practices observed among other large asset management firms, such as BlackRock or State Street, which manage numerous funds and separate accounts.
• The reference to SEC Release No. 34-39538 (January 12, 1998) indicates adherence to established regulatory guidance for such reporting changes.

Stakeholder Impact

• Shareholders: May initially perceive a reduction in institutional ownership, but understanding the disaggregated reporting clarifies that the underlying investment may still exist through other Vanguard entities.
• Investment Professionals: Will need to track beneficial ownership of Outset Medical Inc. across various Vanguard subsidiaries rather than solely through The Vanguard Group, Inc.

Next Steps

• Subsidiaries or business divisions of The Vanguard Group, Inc. will report beneficial ownership of Outset Medical Inc. separately in future filings.

Key Dates

Keywords

Outset Medical Inc, Vanguard Group, Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Institutional Ownership, Investment Management, Portfolio Realignment